To provide additional evidence supporting our hypothesis that LDRAs mediate an autoimmune response via activation of T lymphocytes, particularly Th17 cells, the serum levels of IL-17 in the SLE patients was determined. The gene discussed is IL17A; the disease is systemic lupus erythematosus.